Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ildefonso Espigado"'
Autor:
Antonio Romero, Jaime Pérez-Oteyza, Christelle Ferra, Pascual Balsalobre, Manuel Jurado, José A. Pérez-Simón, Ildefonso Espigado, José L. Díez, Jorge Sierra, Carlos Vallejo, José M. Ribera, Dolores Caballero, Salut Brunet
Publikováno v:
Biology of Blood and Marrow Transplantation. 13:701-706
Many patients receiving allogeneic stem cells develop chronic graft-versus-host disease (cGVHD), which remains as the main cause of morbidity and mortality. Although the first line of therapy is generally with steroids, it is not well known how to ma
Autor:
J Petit, Andrés Insunza, R Arrieta, Miguel A. Sanz, Javier de la Serna, Joan Bargay, Cristina Arbona, David P. Serrano, Adrian Alegre, José M. Ribera, Carmen Martínez, Salut Brunet, Felipe de Arriba, Isabel Sanjuan, Ildefonso Espigado, Luis Benlloch, Miguel Angel Diaz, Dobleta Martínez, María Jesús Pascual, Concha Zamora, Amparo Verdeguer, Consuelo del Cañizo, Javier de la Rubia
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 11:705-709
We have retrospectively evaluated the results of two cycles of mobilization and collection of peripheral blood progenitor cells (PBPC) from 46 healthy donors included in the Spanish National Donor Registry. Mobilization involved the administration of
Autor:
Ildefonso Espigado, Cristina Martínez, Francisco J. Márquez-Malaver, Francesc Fernández-Avilés, Jose F Falantes, Alvaro Urbano-Ispizua, Alicia Báez, Isabel Álvarez-Laderas, María Suárez-Lledó, Beatriz Martín-Antonio, R Cardesa, Magdalena Carmona, M Rovira
Publikováno v:
Bone marrow transplantation. 47(9)
An adequate response of the innate immune system after allo-SCT is crucial for the clinical outcome of patients submitted to this procedure. EP300 is one of the key genes of the innate immune system (IIS). We evaluated the influence of gene variant A
Autor:
A. Urbano-Ispizua, J.M. Cisneros-Herreros, Pilar Pérez-Romero, Manuela Aguilar-Guisado, Ildefonso Espigado, F. de la Cruz-Vicente
Publikováno v:
Transplantation proceedings. 42(8)
Fifty percent of allogeneic stem cell recipients develop cytomegalovirus (CMV) infection in the first 100 days posttransplantation. Various methods have been used to determine CMV infections, including antigenemia assay and real-time polymerase chain
Autor:
David Gallardo, Enric Carreras, Salut Brunet, Carlos Vallejo, Dolores Caballero, Josep M. Ribera, Javier de la Rubia, Carmen Martín, Carlos Solano, Jose B Nieto, David P. Serrano, Antonio Jiménez-Velasco, Arturo Iriondo, Ildefonso Espigado, Rafael de la Cámara
Publikováno v:
HAEMATOLOGICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Granulocyte colony-stimulating factor mobilized peripheral blood stem cells are increasingly used instead of bone marrow as a stem cell source for transplantation. Whereas this change is almost complete for autologous transplantation, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa89cf0b98f5bcf36a0acfe010b0d557
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13169
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13169
Autor:
Javier Zuazu, Marcos González, Antoni Torres, Enric Carreras, Salut Brunet, Rafael de la Cámara, José Alberto San Román, Jaime Pérez de Oteyza, Carlos Vallejo, Santiago Osorio, David Gallardo, Antonio M. Jimenez, Ildefonso Espigado, Jorge Sierra, M. Francisca González-Escribano, Manuela Alonso-Nieto, Juan R. González, Carmen Martiín, Guillermo Sanz, C Sanz-Rodriguez, David P. Serrano
Publikováno v:
Transplantation. 77(7)
Background The role of human leukocyte antigen (HLA)-DPB1 as a transplantation antigen is controversial. A higher incidence of acute graft-versus-host disease (aGVHD) has been described after unrelated donor bone marrow transplant when both HLA-DPB1